Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Vasundhara Tolia"'
Autor:
Martin Tobi, Douglas Weinstein, Mijin Kim, James Hatfield, Paula Sochacki, Edi Levi, Teisa An, Merlin Hamre, Vasundhara Tolia, Suzanne Fligiel, Rama Marepally, Jason Hallman, Bharati Bapat, Mei Yuan, Benita McVicker, Steven Gallinger
Publikováno v:
Current Oncology, Vol 30, Iss 9, Pp 7950-7963 (2023)
Background: We evaluated the phenotype of sporadic gastric cancer based on HP status and binding of a tumor risk marker monoclonal, Adnab-9. Methods: We compared a familial GC kindred with an extremely aggressive phenotype to HP-positive (HP+) and -n
Externí odkaz:
https://doaj.org/article/e8a1796217794052b7ac6e6a78b3fc92
Autor:
Harland S. Winter, Vasundhara Tolia, Frédéric Gottrand, Thirumazhisai S. Gunasekaran, Marta Illueca, Peter Barker
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 60:S9-S15
OBJECTIVES Gastroesophageal reflux disease (GERD) is present in pediatric patients when reflux of gastric contents causes troublesome symptoms and/ or complications. The present study evaluates the efficacy and safety of esomeprazole in infants ages
Autor:
Jennifer E. Hamer-Maansson, Vasundhara Tolia, Per Lundborg, Marta Illueca, Eduardo Tron, Nader N. Youssef
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 52:965-972
To assess the overall exposure after a single dose of esomeprazole in children with gastroesophageal reflux disease (GERD).Oral esomeprazole administered as an intact capsule with 30 - 180 mL of water, or as an opened capsule mixed with as much as 1
Autor:
Pippa Simpson, Vasundhara Tolia, Shailender Madani, Victoria Tutag Lehr, Mary Lieh Lai, Ashok Sarniak, Ralph E. Kauffman
Publikováno v:
The Journal of Clinical Pharmacology. 54:201-205
To characterize and compare acid suppression (pharmacodynamics) and pharmacokinetics of IV famotidine and ranitidine in critically ill children at risk for stress gastritis. Single-blind, randomized study in PICU patients 6 months to 18 years requiri
Autor:
Vasundhara Tolia, Harohalli Shashidhar
Publikováno v:
Expert Opinion on Pharmacotherapy. 14:2475-2487
A common diagnostic entity in children is Esophagitis with multiple etiologies and complex immuno-pathogenic mechanisms. Our understanding of these mechanisms and of the pharmacotherapy of esophagitis is still evolving.Areas of focus for this review
Autor:
Marie Sandström, Kurt Brown, Per Lundborg, Vasundhara Tolia, Janice E. Sullivan, Geoffrey P. Davidson, Göran Långström
Publikováno v:
Clinical Therapeutics. 34:1828-1838
Background Several oral proton pump inhibitors (PPIs) are currently approved for use in pediatric patients in North America and Europe. However, when use of oral therapy is not possible or appropriate, intravenous formulations of PPIs may be helpful.
Autor:
Vasundhara Tolia
Publikováno v:
Therapy. 8:515-526
This article summarizes the effect of pantoprazole, a proton pump inhibitor (PPI) on suspected or objectively demonstrated gastroesophageal reflux disease (GERD) symptoms in pediatric age range from premature infants to 16 years of age. All intervent
Publikováno v:
Therapy. 6:65-73
The word peptic implies ‘gastric-, pepsin- or acid-related’. Peptic ulcer disease (PUD) denotes the presence of gastric and/or duodenal ulceration or erosion. In clinical practice, the term encompasses gastric or duodenal infl ammation due to any
Publikováno v:
Therapy. 6:83-91
Nonalcoholic fatty liver disease (NAFLD) is probably the most common form of chronic liver disease in children in the USA and may continue to rise with the increasing prevalence of childhood obesity and metabolic syndrome. Although the exact pathophy
Autor:
Vasundhara Tolia
Publikováno v:
Pediatric Health. 2:687-696
Acid-related disorders are frequently encountered in pediatric practice. In addition to lifestyle modifications, effective management by suppression of gastric acid production is the most important management strategy for gastroesophageal reflux dise